- Country: Serbia
- Summary: Drugs for Human Use
- RST Ref No: 98675288
- Deadline: 25 Mar 2024
- Financier: Self Financed
- Purchaser Ownership: Government
- Tender Value: RSD 4734969.70
- Notice Type: Tender
- Document Ref. No.: JN OP 6/2024
- Purchaser's Detail:Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
- Description:
- Albumin-human 5% 250ml, Albumin-human 20% 50ml, Amoxicillin clavulanic acid inj./inf. (1000 200)mg, Meropenem inj./inf.1g, Ceftriaxon inj./inf.1g, Pantoprazole inj./inf. 40mg, Rocuronium-bromide inj/inf 50mg/5ml, nadroparin-calcium 0.3ml, nadroparin-calcium 0.4ml, nadroparin-calcium 0.6ml, Glucose 5% 500ml, Glucose 10% 500 ml, Sodium-chloride potassium-chloride calcium-chloride sodium-lactate (6g 0.4g 0.27g 6.24g) L 500ml, Metoclopramide-chloride 10mg/2ml, Levofloxacin inf.500mg/1 00ml, Natrium chloride 0.9% 500ml. ,Ondansetron i.4mg/2ml, Paracetamol inf.100ml (10mg/ml), Propofol 1 mg/ml 200mg/20ml, Natrium-chloride potassium- chloride calcium-chloride inf. (8.6g 0.3g 0.33g) L 500ml
- Documents:
If you are registered member, kindly login to view full details of this tender notice:
CLICK HERE TO LOGINDrugs for Human Use - Serbia Tender
The "INSTITUTE FOR PULMONARY DISEASES OF VOJVODINA, a Government sector organization in Serbia, has announced a new tender for Drugs for Human Use. This tender is published on SerbiaTenders under RST Ref No: 98675288 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2024-03-25.
The estimated tender value is RSD 4734969.70, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.
